Transcultural Psychiatry
January 6, 2022
Eduardo Ekman Schenberg, Konstantin Gerber
18 citations
After decades of biomedical research on ayahuasca's molecular compounds and their physiological effects, recent clinical trials show evidence of therapeutic potential for depression. However, indigenous peoples have been using ayahuasca therapeutically for a very long time, and thus we question the epistemic authority attributed to scientific studies, proposing that epistemic injustices were...
Evidence-based Complementary and Alternative Medicine
January 4, 2022
P Upadhyay, T F H Chang, S Hariri et al.
In recent years, mindfulness-based interventions (MBIs) are rapidly growing in the workplace. Several meta-analyses conclude that overall MBIs have a moderate effect of alleviating deficit-based experiences, such as burnout and stress, but a small to no effect of promoting asset-based experiences, such as positive affect and well-being. While workplace MBIs vary greatly in their content,...
Frontiers in Psychiatry
January 3, 2022
Richard Matzopoulos, Robert Morlock, Amy Morlock et al.
43 citations
Introduction: Popular media coverage of psychedelics use, growing research into this class of compounds for psychiatry and decriminalization initiatives, are transforming the public perception of psychedelics. However, little is known about levels of knowledge and psychedelic mushroom (PM) use among American adults. Methods: We examined PM use and various measures of health status, quality of...
Progress in Palliative Care
January 2, 2022
A. C. Garcia, L. O. Maia
The healthcare field and society at large are witnessing a resurgence of interest in the effects and applications of psychedelic therapies in a wide range of settings. In the 1950s and 1960s, research was conducted to explore different applications for psychedelics, such as lysergic acid diethylamide (LSD) and mescaline, in the healthcare setting. However, psychedelic research was dramatically...
Applied Nursing Research
2022
V. Sulosaari, Eda Unal, F. Cinar
BACKGROUND There is a rising demand for methods to support well-being at work. Mindfulness-based interventions have the potential to enhance nurses' psychological well-being. PURPOSE To identify mindfulness-based interventions and outcome measures and to evaluate the effect on the psychological well-being of nurses. METHODS A systematic review following Prisma protocol with search of four...
World Journal of Clinical Cases
2022
Jing Li, Yun-Yun Zhang, Xiao-Yin Cong et al.
Background: Mindfulness meditation is beneficial to mitigate the negative effects of the coronavirus disease 2019 (COVID-19) pandemic in the general population, but no study examined such meditation in the COVID-19 patients themselves. Aim: To explore the short-term efficacy of mindfulness meditation in alleviating psychological distress and sleep disorders in patients with COVID-19. Methods:...
Progress in Neuro-Psychopharmacology and Biological Psychiatry
2022
A. Camargo, A. C. N. Torrá, A. P. Dalmagro et al.
Ketamine enhances the resilience against stress-induced depressive-like behavior, but its prophylactic efficacy in anxiety-related behaviors remains to be elucidated. Moreover, there is a need for developing novel preventive strategies against depressive- and anxiety-like behavior. AZD6765, a low-trapping NMDA receptor antagonist, shares with ketamine common molecular targets and produces...
2022
Matheus Lujan Pereira, Tânia Marcourakis
INTRODUÇÃO: Os psicodélicos são substâncias que afetam diversos processos cognitivos, causando alterações comportamentais e perceptivas. A psilocibina e seu metabólito ativo, a psilocina, foram identificados como os compostos psicoativos nos Laboratórios Sandoz em 1958 por Albert Hofmann. A psilocibina tem uma estrutura semelhante à serotonina, portanto acredita-se que ela tenha uma ação...
ABSTRACT BOOK 2022
2022
1. Objetivos: El objetivo principal de este estudio ha sido revisar las distintas drogas psicodélicas que han sido estudiadas hasta el momento como posibles nuevas terapias para el abordaje de trastornos psiquiátricos. Como objetivos secundarios: - Estudiar la psilocybina como tratamiento para la depresión resistente. - Conocer el uso de drogas psicodélicas en pacientes post Covid-19 con...
International Journal of Yoga Therapy
January 1, 2022
Elizabeth Elsmore, Steven Hawks, Roberta May et al.
Despite increased interest in mindfulness practices such as yoga as an adjunct for depression, anxiety, and other chronic health concerns, little research exists on the potential benefits of yoga in therapeutic settings. As a complementary therapy, yoga provides a value-added benefit to traditional clinical practices for (1) clinicians as a form of self-care in treating compassion fatigue...